Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New factor Xa/factor VIIa inhibitors covered by Merck KGaA patent

Feb. 13, 2004

Nuvelo licenses rNAPc from Dendreon

Feb. 9, 2004

The SPORTIF trials provide new data on ximelagatran in the prevention of stroke

Feb. 9, 2004

Aniline-based factor VIIa inhibitors newly identified at BMS

Feb. 5, 2004

Novel carboxypeptidase U inhibitors identified by AstraZeneca researchers

Feb. 3, 2004

Biovitrum to be sole supplier of ReFacto

Jan. 28, 2004

European approval for Mononine continuous intravenous infusion

Jan. 26, 2004

Abciximab and clopidogrel in elective PCI

Jan. 22, 2004

ProAlgaZyme may decrease risk of stroke or heart attack

Jan. 22, 2004

Guilford launches marketing efforts for Aggrastat, plans PCI registration study

Jan. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...